Researchers have built a realistic human mini spinal cord in the lab and used it to simulate traumatic injury. The model reproduced key damage seen in real spinal cord injuries, including inflammation ...

For years, hair-loss research cycled through big promises, but had modest results to show for it at best. Over the past five ...

Cell and gene therapies, or CGT, have come a long way since they were first introduced. In the last few decades, both cell therapy -- the transplantation of living cells -- and gene therapy -- the use ...

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a late stage clinical regenerative ...

For the first time ever, an anti-aging drug is providing hope for millions who suffer from this common condition.

King's College London researchers have created a unique collection of human stem cell models that could help to uncover why ...

CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. "As we ...

ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025.

A newly identified protein may hold the key to rejuvenating aging brain cells. Researchers found that boosting DMTF1 can ...

The International Society for Stem Cell Research (ISSCR) is pleased to announce that Aviv Regev, PhD, Head of Research and Early Development at Genentech, will serve as a keynote speaker at the ISSCR ...